BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 637610)

  • 1. The effect of glucagon in animals on chronic propranolol therapy.
    Peterson A; Lucchesi B; Kirsh MM
    Ann Thorac Surg; 1978 Apr; 25(4):340-5. PubMed ID: 637610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic antagonism of propranolol in dogs. III. Effects of dopamine-isoproterenol and glucagon on hemodynamics and myocardial oxygen consumption in ischemic hearts during chronic propranolol administration.
    Wei J; Spotnitz HM; Spotnitz WD; Benvenisty AI; Haasler GB; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1984 May; 87(5):732-42. PubMed ID: 6717051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual effects when chronic propranolol therapy is discontinued within 48 hours of cardiopulmonary bypass.
    Frank G; Tyers O; Hughes HC
    Am Heart J; 1976 Jun; 91(6):757-65. PubMed ID: 1274827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of glucagon on canine left ventricular performance and coronary hemodynamics.
    Abel FL
    Circ Shock; 1983; 11(1):45-58. PubMed ID: 6640854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine model.
    Love JN; Leasure JA; Mundt DJ
    Am J Emerg Med; 1993 Jul; 11(4):360-3. PubMed ID: 8216517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular performance and pulmonary circulation following addition of nitrous oxide to morphine during coronary-artery surgery.
    Lappas DG; Buckley MJ; Laver MB; Daggett WM; Lowenstein E
    Anesthesiology; 1975 Jul; 43(1):61-9. PubMed ID: 1147309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
    Dowell RT; Houdi AA
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory effects of propranolol and cardiopulmonary bypass.
    Tyers GF; Hughes HC
    J Surg Res; 1975 Feb; 18(2):181-4. PubMed ID: 1134084
    [No Abstract]   [Full Text] [Related]  

  • 13. Substrate cardioplegia during hypothermic arrest in the alloxan diabetic dog.
    Clancy PE; Slater AD; Brandt D; Kirsh MM
    Ann Thorac Surg; 1981 Jun; 31(6):558-63. PubMed ID: 7018431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.
    Jolly SR; Kipnis JN; Lucchesi BR
    Pharmacology; 1987; 35(5):249-55. PubMed ID: 3423100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.
    Parratt JR
    Br J Pharmacol; 1974 May; 51(1):5-13. PubMed ID: 4155336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the haemodynamic effects of propranolol, 4-hydroxypropranolol and practolol in anaesthetized dogs.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1972 Jun; 45(2):207-17. PubMed ID: 4403100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease.
    Rocha P; Zannier D; Baron B; Pathe M; David D; Kahn JC
    Am J Cardiol; 1987 Apr; 59(8):775-81. PubMed ID: 3825937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ketamine on left ventricular performance.
    Schwartz DA; Horwitz LD
    J Pharmacol Exp Ther; 1975 Aug; 194(2):410-4. PubMed ID: 1151766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.